Tolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-old
NCT03155217
·
clinicaltrials.gov ↗
COMPLETED
Status
358
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Melanoma
Sponsor
University Hospital, Montpellier
Collaborators
[object Object]